Increased macrophage inflammatory protein-1α and -1β in BAL fluid of bronchiolitis obliterans organizing pneumonia

Respirology

Volumn 8, Issue 4, 2003, Pages 461-466

  Asano, Toru ^a   Ogushi, Fumitaka ^a   Tani, Kenji ^a   Tamiya, Hiroyuki ^a   Nishioka, Yasuhiko ^a   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

BAL fluid; Bronchiolitis obliterans organizing pneumonia; Chemokine; Macrophage inflammatory protein 1

Indexed keywords

BETA CHEMOKINE; CORTICOSTEROID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ADULT; AGED; ARTICLE; BRONCHIOLITIS; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; LUNG LAVAGE; LYMPHOCYTE; MALE; MONOCYTE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ADULT; AGED; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; FEMALE; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED;

EID: 0346257948     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2003.00496.x     Document Type: Article

References (37)

1. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N. Engl. J. Med. 1985; 312: 152-8.
2. Cordier JF, Loire R, Brune J. Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients. Chest 1989; 96: 999-1004.
3. Izumi T, Kitaichi M, Nishimura K, Nagai S. Bronchiolitis obliterans organizing pneumonia: Clinical features and differential diagnosis. Chest 1992; 102: 715-19.
4. Muller NL, Guerry-Force ML, Staples CA et al. Differential diagnosis of bronchiolitis obliterans with organizing pneumonia and usual interstitial pneumonia: clinical functional and radiologic findings. Radiology 1987; 162: 151-6.
5. Guerry-Force ML, Muller NL, Wright JL et al. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia, and small airways disease. Am. Rev. Respir. Dis. 1987; 135: 705-12.
6. Myers JL, Katzenstein ALA. Ultrastructural evidence of alveolar epithelial injury in idiopathic bronchiolitis obliterans organizing pneumonia. Am. J. Pathol. 1988; 132: 102-9.
7. Peyrol S, Cordier JF, Grimaud JA. Intra-alveolar fibrosis of idiopathic bronchiolitis obliterans organizing pneumonia. Cell matrix patterns. Am. J. Pathol. 1990; 137: 155-70.
8. Muller NL, Staples CA, Miller RR. Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. AJR Am. J. Roentgenol. 1990; 154: 983-7.
9. Nagai S, Aung H, Tanaka S et al. Bronchoalveolar lavage cell findings in patients with BOOP and related diseases. Chest 1992; 102: 32S-37S.
10. Costabel U, Teschler H, Guzman J. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur. Respir. J. 1992; 5: 791-7.
11. Strieter RM, Standiford TJ, Huffnagle GB, Colletti LM, Lukacs NW, Kunkel SL. 'The good, the bad, and the ugly'. The role of chemokines in models of human disease. J. Immunol. 1996; 156: 3583-6.
12. Adams DH, Lloyd AR. Chemokines: leucocyte recruitment and activation cytokines. Lancet 1997; 349: 490-5.
13. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines. CXC and CC chemokines. Adv. Immunol. 1994; 55: 97-179.
14. Tani K, Su SB, Utsunomiya I, Oppenheim JJ, Wang JM. Interferon-gamma maintains the binding and functional capacity of receptors for IL-8 on cultured human T cells. Eur. J. Immunol. 1998; 28: 502-7.
15. Murphy PM, Baggiolini M, Charo IF et al. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000; 52: 145-76.
16. Hase K, Tani K, Shimizu T, Ohmoto Y, Matsushima K, Sone S. Increased CCR4 expression in active systemic lupus erythematosus. J. Leukoc. Biol. 2001; 70: 749-55.
17. Huffnagle GB, Strieter RM, Standiford TJ et al. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 1995; 155: 4790-7.
18. Cruikshank WW, Long A, Tarpy RE et al. Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1α (MIP-1α) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am. J. Respir. Cell Mol. Biol. 1995; 13: 738-47.
19. Sousa AR, Lane SJ, Nakhosteen JA, Yoshimura T, Lee TH, Poston RN. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 1994; 10: 142-7.
20. Alam R, York J, Boyars M et al. Increased MCP-1, RANTES, and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients. Am. J. Respir. Crit. Care Med. 1996; 153: 1398-404.
21. Denis M. Proinflammatory cytokines in hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 1995; 151: 164-9.
22. Capelli A, Di Stefano A, Gnemmi I et al. Increased MCP-1 and MIP-1β in bronchoalveolar lavage fluid of chronic bronchitics. Eur. Respir. J. 1999; 14: 160-5.
23. Kadota J, Mukae H, Tomono K, Kohno S. High concentrations of beta-chemokines in BAL fluid of patients with diffuse panbronchiolitis. Chest 2001; 120: 602-7.
24. Petrek M, Pantelidis P, Southcott AM et al. The source and role of RANTES in interstitial lung disease. Eur. Respir. J. 1997; 10: 1207-16.
25. Oshima M, Maeda A, Ishioka S, Hiyama K, Yamakido M. Expression of C-C chemokines in bronchoalveolar lavage cells from patients with granulomatous lung diseases. Lung 1999; 177: 229-40.
26. Capelli A, Di Stefano A, Lusuardi M, Gnemmi I, Donner CF. Increased macrophage inflammatory protein-1α and macrophage inflammatory protein-1β levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 2002; 165: 236-41.
27. Smith RE, Strieter RM, Zhang K et al. A role for C-C chemokines in fibrotic lung disease. J. Leukoc. Biol. 1995; 57: 782-7.
28. Standiford TJ, Rolfe MW, Kunkel SL et al. Macrophage inflammatory protein-1α expression in interstitial lung disease. J. Immunol. 1993; 151: 2852-63.
29. Bolster MB, Ludwicka A, Sutherland SE, Strange C, Silver RM. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum. 1997; 40: 743-51.
30. Tani K, Ogushi F, Huang L et al. CD13/aminopeptidase N, a novel chemoattractant for T lymphocytes in pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 2000; 161: 1636-42.
31. Kawano T, Ogushi F, Tani K et al. Comparison of suppressive effects of a new anti-inflammatory compound, FR167653, on production of PGE2 and inflammatory cytokines, human monocytes, and alveolar macrophages in response to endotoxin. J. Leukoc. Biol. 1999; 65: 80-6.
32. Driscoll KE. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp. Lung Res. 1994; 20: 473-90.
33. Ziegenhagen MW, Schrum S, Zissel G, Zipfel PF, Schlaak M, Muller-Quernheim J. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J. Investig. Med. 1998; 46: 223-31.
34. Hasegawa M, Sato S, Takehara K. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α) and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis. Clin. Exp. Immunol. 1999; 117: 159-65.
35. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 1993; 260: 355-8.
36. Katoh S, Matsumoto N, Fukushima K et al. Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. J. Allergy Clin. Immunol. 2000; 106: 730-6.
37. Oliveira SH, Lira S, Martinez AC, Wiekowski M, Sullivan L, Lukacs NW. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8. J. Leukoc. Biol. 2002; 71: 1019-25.